Bridging the gap between academic discovery and commercial translation Industry leaders at the Advanced Therapies conference outline how early collaboration, funding, and culture shape whether breakthroughs reach patients.

https://www.drugdiscoverynews.com/bridging-the-gap-between-academic-discovery-and-commercial-translation-17086 DDN recently attended the Advanced Therapies conference held in London on the March 17–18 and found one theme that resonated across many discussions. Translating brilliant scientific discoveries into real-world treatments remains a major challenge. Across the UK and Europe, universities produce world-class research, yet far fewer advanced therapies reach patients compared with the US or China. The reasons, as multiple leaders explained, go beyond science — they lie in structure, culture, and early engagement.